Financial statements Biovigen

Balance sheet of Biovigen

Company age:
Age:
12 y. 10 m. 12 d.
Share capital:
Share capital:
30 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BIOVIGEN

Year
2019
2020
2021
2022
2023
Total assets 1 068 900,90 1 883 013,83 1 141 329,21 1 754 651,33 1 960 906,35
A. Fixed assets 42 361,83 32 331,15 40 792,69 45 107,50 42 333,78
B. Current assets 1 026 539,07 1 850 682,68 1 100 536,52 1 709 543,83 1 918 572,57
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 1 068 900,90 1 883 013,83 1 141 329,21 1 754 651,33 1 960 906,35
A. Equity 567 764,93 862 304,33 409 346,40 667 861,13 1 421 750,89
B. Liabilities and provisions for liabilities 501 135,97 1 020 709,50 731 982,81 1 086 790,20 539 155,46
I. Long-term liabilities - - - - -
II. Short-term liabilities - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.